SOHO State of the Art Updates and Next Questions | Predictive Markers for Ruxolitinib in Myelofibrosis. // Clinical Lymphoma, Myeloma & Leukemia. – URL: https://www.sciencedirect.com/science/article/pii/S215226502600217X?dgcid=rss_sd_all
SOHO State of the Art Updates and Next Questions | Predictive Markers for Ruxolitinib in Myelofibrosis. Clinical Lymphoma, Myeloma & Leukemia. https://www.sciencedirect.com/science/article/pii/S215226502600217X?dgcid=rss_sd_all
“SOHO State of the Art Updates and Next Questions | Predictive Markers for Ruxolitinib in Myelofibrosis.” Clinical Lymphoma, Myeloma & Leukemia.
@article{article97698,
title = {SOHO State of the Art Updates and Next Questions | Predictive Markers for Ruxolitinib in Myelofibrosis},
journal = {Clinical Lymphoma, Myeloma \& Leukemia},
url = {https://www.sciencedirect.com/science/article/pii/S215226502600217X?dgcid=rss_sd_all}
}